Yet, combination treatment targeting these markers such as VEGF has meager efficacy and inexorable cytotoxic effect due to acquired resistance,8 which demonstrates the need for more studies on novel hub molecules and signaling pathways fueling malignant vascularization in GBM given its peculiarity.9 This evidence concerns the gene VEGFA and glioblastoma.